Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.134 USD | +3.00% | +1.90% | -16.77% |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 22-07-31 | |
David Jin
DFI | Director of Finance/CFO | 34 | - |
Michael Ryan
CTO | Chief Tech/Sci/R&D Officer | - | 18-08-31 |
Scott A. Reines
CTO | Chief Tech/Sci/R&D Officer | 77 | 15-12-31 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 15-02-08 | |
Jay Kranzler
CHM | Chairman | 66 | 17-01-31 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 15-07-31 |
Faith Charles
BRD | Director/Board Member | 62 | 22-05-15 |
Curtis Oltmans
BRD | Director/Board Member | 60 | 21-03-31 |
Chief Executive Officer | 57 | 22-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,260,667 | 39,032,066 ( 88.19 %) | 0 | 88.19 % |
Stock B | 0 | 250,000 | 0 | 0 |
Company contact information
Avenue Therapeutics, Inc.
1111 Kane Concourse Suite 301
33154, Bay Harbor Islands
+781 652 4500
http://www.avenuetx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.39% | 5.76M | |
-0.46% | 103B | |
+3.66% | 96.73B | |
+1.66% | 21.31B | |
-16.09% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-23.16% | 13.68B | |
+6.05% | 13.44B | |
+22.71% | 10.98B |
- Stock Market
- Equities
- ATXI Stock
- Company Avenue Therapeutics, Inc.